INO-5401 and INO-9012 in combination with cemiplimab REGN2810 - Will this data effect clinicians today? - David A. Reardon, MD Dana-Farber Cancer Institute @DanaFarber #glioblastoma

INO-5401 and INO-9012 in combination with cemiplimab REGN2810 - Will this data effect clinicians today? - David A. Reardon, MD Dana-Farber Cancer Institute @DanaFarber #glioblastoma

User Photo
Cancer-News

1 month
73 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
David A. Reardon, MD Dana-Farber Cancer Institute discusses INO-5401 and INO-9012 in combination with cemiplimab REGN2810 in newly diagnosed glioblastoma GBM Interim results. - How will this affect clinicians today?
Up Next Autoplay